EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Sarcomatoid renal cell tumor harboring a novel BYSL :: TFEB fusion with concurrent TFEB amplification

Ruihe Lin, Elizaveta Flerova, Christine E Wamsley, Peter A McCue, Costas D Lallas, Wei Jiang, Jialing Huang, Zi-Xuan Wang, Li Li iD

Genes, Chromosomes and Cancer · 2023

DOI: 10.1002/gcc.23125 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Ruihe Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcription factor EB ( TFEB )‐rearranged renal cell carcinoma (RCC) exhibits diverse gene fusion patterns and heterogeneous clinicopathologic features. Rare TFEB‐ amplified RCCs have been described recently and are associated with a more aggressive clinical course. Herein, we report a case of an 86‐year‐old man with a solid 9.2‐cm kidney tumor that showed a diffuse high‐grade sarcomatoid morphology. The tumor demonstrated a novel BYSL::TFEB fusion containing exons 1–2 of the BYSL gene fused to exons 3–10 of TFEB via next‐generation sequencing by using NextSeq sequencer. Fluorescence in situ hybridization (FISH) studies displayed concurrent high‐copy number TFEB amplification in two distinct patterns, a balanced increase of 5′ and 3′ copies, and solely increased 5′ copies, and mouse double minute 2 ( MDM2 ) gene amplification by using TFEB (6p21.1) dual‐color break‐apart probe and MDM2 FISH probe. Notably, the tumor showed a distinctive immunoprofile with overexpressions of TFEB, epithelial membrane antigen, Cathepsin K, and PDL‐1 (SP263). FISH test for transcription factor binding to IGHM enhancer 3 ( TFE3 ) was negative for rearrangement and corresponding immunonegativity of TFE3. These findings not only expand the repertoire of known TFEB fusion partners implicated in tumorigenesis, but also may provide novel information for target therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellSarcomaSoft Tissue NeoplasmsHumansAnimalsMiceIn Situ Hybridization, FluorescenceBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsExonsBiomarkers, TumorTranslocation, GeneticCell Adhesion Molecules

Stichwörter der Autor:innen

BYSL-TFEB fusionMDM2 amplificationTFEB amplificationfluorescence in situ hybridization (FISH)next-generation sequencing (NGS)renal cell carcinomasarcomatoid

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorTFEB protein, humanBYSL protein, humanCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
  • Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Li Li

Zitieren

APA

Lin, R., Flerova, E., Wamsley, C. E., McCue, P. A., Lallas, C. D., Jiang, W., Huang, J., Wang, Z. X., & Li, L. (2023). Sarcomatoid renal cell tumor harboring a novel BYSL :: TFEB fusion with concurrent TFEB amplification. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23125

Vancouver

Lin R, Flerova E, Wamsley CE, McCue PA, Lallas CD, Jiang W, et al. Sarcomatoid renal cell tumor harboring a novel BYSL :: TFEB fusion with concurrent TFEB amplification. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23125

BibTeX
@article{Lin2023,
  author = {Lin, Ruihe and Flerova, Elizaveta and Wamsley, Christine E and McCue, Peter A and Lallas, Costas D and Jiang, Wei and Huang, Jialing and Wang, Zi-Xuan and Li, Li},
  title = {Sarcomatoid renal cell tumor harboring a novel BYSL :: TFEB fusion with concurrent TFEB amplification},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  doi = {10.1002/gcc.23125}
}
Kostenlos starten →